Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Graft thrombosis (up to 18 months) · people with ESRD receiving haemodialysis through an arteriovenous graft

Dipyridamole showed no clear difference in graft thrombosis (up to 18 months) compared with placebo (moderate certainty).

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
OR 0.46 [0.11, 1.94]
1 study · 42 participants
Moderate

Graft thrombosis (up to 18 months) · people with ESRD receiving haemodialysis through an arteriovenous graft

Dipyridamole plus aspirin showed no clear difference in graft thrombosis (up to 18 months) compared with placebo (moderate certainty).

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
OR 0.64 [0.16, 2.56]
1 study · 41 participants
Moderate